FDA approves phase 2 trial for coronavirus vaccine

The Food and Drug Administration cleared a coronavirus vaccine for a phase 2 trial. Moderna said it will begin phase 2 trials with 600 participants shortly and is finalizing plans for a phase 3 trial as early as this summer.